Document ID: chunk:federal_register_of_legislation:F2024L01389:schedule:1:p40
Version: federal_register_of_legislation:F2024L01389
Segment Type: schedule
Provision Reference: sch 1 (pt 40/66)
Character Range: 109529–113263

mL  Oral  Vfend                PF  MP NP  C15979 C15981 C16042 C16094 C16115                               1   0     1

Voriconazole  Tablet 50 mg                                    Oral  Voriconazole Sandoz  SZ  MP NP  C16115                              P16115                       56  0     56
Voriconazole  Tablet 50 mg                                    Oral  Voriconazole Sandoz  SZ  MP NP  C15979 C15981 C16042 C16094         P15979 P15981 P16042 P16094  56  2     56
Voriconazole  Tablet 50 mg                                    Oral  Vttack               AF  MP NP  C16115                              P16115                       56  0     56
Voriconazole  Tablet 50 mg                                    Oral  Vttack               AF  MP NP  C15979 C15981 C16042 C16094         P15979 P15981 P16042 P16094  56  2     56
Voriconazole  Tablet 50 mg                                    Oral  Vzole                RW  MP NP  C16115                              P16115                       56  0     56
Voriconazole  Tablet 50 mg                                    Oral  Vzole                RW  MP NP  C15979 C15981 C16042 C16094         P15979 P15981 P16042 P16094  56  2     56
Voriconazole  Tablet 200 mg                                   Oral  Voriconazole Sandoz  SZ  MP NP  C16115                              P16115                       56  0     56
Voriconazole  Tablet 200 mg                                   Oral  Voriconazole Sandoz  SZ  MP NP  C15979 C15981 C16042 C16094         P15979 P15981 P16042 P16094  56  2     56
Voriconazole  Tablet 200 mg                                   Oral  Vttack               AF  MP NP  C16115                              P16115                       56  0     56
Voriconazole  Tablet 200 mg                                   Oral  Vttack               AF  MP NP  C15979 C15981 C16042 C16094         P15979 P15981 P16042 P16094  56  2     56
Voriconazole  Tablet 200 mg                                   Oral  Vzole                RW  MP NP  C16115                              P16115                       56  0     56
Voriconazole  Tablet 200 mg                                   Oral  Vzole                RW  MP NP  C15979 C15981 C16042 C16094         P15979 P15981 P16042 P16094  56  2     56

[286] Schedule 1, Part 1, entry for Zolmitriptan [Brand: Zomig]
omit from the column headed "Responsible Person": AP substitute: AS
[287] Schedule 1, Part 1, entry for Zuclopenthixol decanoate
insert in the column headed "Circumstances": C15956
[288] Schedule 1, Part 2, omit entry for Carbomer 974
[289] Schedule 1, Part 2, omit entry for Hypromellose with dextran
[290] Schedule 1, Part 2, omit entry for Mepolizumab
[291] Schedule 1, Part 2, omit entry for Risankizumab
[292] Schedule 3,
omit:
CJ  Celgene Pty Limited  42 118 998 771

[293] Schedule 4, Part 1, entry for Circumstances Code "C4246"
insert in alphabetical order in the column headed "Listed Drug": Olanzapine
[294] Schedule 4, Part 1, omit entry for Circumstances Code "C4260"
[295] Schedule 4, Part 1, entry for Circumstances Code "C4268"
insert in alphabetical order in the column headed "Listed Drug": Apixaban
[296] Schedule 4, Part 1, entry for Circumstances Code "C4295"
(a) insert in alphabetical order in the column headed "Listed Drug": Glycomacropeptide formula with amino acids and low phenylalanine
(b) insert in alphabetical order in the column headed "Listed Drug": Glycomacropeptide formula with amino acids, vitamins, minerals, trace elements, carbohydrate, fat and low phenylalanine
[297] Schedule 4, Part 1, omit entry for Circumstances Code "C4304"
[298] Schedule 4, Part 1, omit entry for Circumstances Code "C4683"
[299] Schedule 4, Part 1, omit entry for Circumstances Code "C4685"
[300]